Number of the records: 1  

Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX

  1. 1.
    0511423 - ÚOCHB 2020 RIV US eng J - Journal Article
    Grüner, B. - Brynda, Jiří - Das, V. - Šícha, V. - Štěpánková, J. - Nekvinda, J. - Holub, J. - Pospíšilová, Klára - Fábry, M. - Pachl, Petr - Král, V. - Kugler, Michael - Mašek, V. - Medvedíková, M. - Matějková, Stanislava - Nová, A. - Lišková, B. - Gurská, S. - Džubák, P. - Hajdúch, M. - Řezáčová, Pavlína
    Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX.
    Journal of Medicinal Chemistry. Roč. 62, č. 21 (2019), s. 9560-9575. ISSN 0022-2623. E-ISSN 1520-4804
    R&D Projects: GA TA ČR(CZ) TE01020028; GA MŠMT(CZ) LM2015064
    Institutional support: RVO:61388963
    Keywords : cobalt bis(1,2-dicarbollide) * carborane complexes * medicinal chemistry
    OECD category: Biochemistry and molecular biology
    Impact factor: 6.205, year: 2019
    Method of publishing: Limited access
    https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.9b00945

    Carbonic anhydrase IX (CAIX) is a transmembrane enzyme that regulates pH in hypoxic tumors and promotes tumor cell survival. Its expression is associated with the occurrence of metastases and poor prognosis. Here, we present nine derivatives of the cobalt bis(dicarbollide)(1−) anion substituted at the boron or carbon sites by alkysulfamide group(s) as highly specific and selective inhibitors of CAIX. Interactions of these compounds with the active site of CAIX were explored on the atomic level using protein crystallography. Two selected derivatives display subnanomolar or picomolar inhibition constants and high selectivity for the tumor-specific CAIX over cytosolic isoform CAII. Both derivatives had a time-dependent effect on the growth of multicellular spheroids of HT-29 and HCT116 colorectal cancer cells, facilitated penetration and/or accumulation of doxorubicin into spheroids, and displayed low toxicity and showed promising pharmacokinetics and a significant inhibitory effect on tumor growth in syngenic breast 4T1 and colorectal HT-29 cancer xenotransplants.
    Permanent Link: http://hdl.handle.net/11104/0301695

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.